Cite
HARVARD Citation
Romano, F. et al. (2022). Clinical and genetic analysis of patients with segmental overgrowth features and somatic mammalian target of rapamycin (mTOR) pathway disruption: Possible novel clinical issues. Birth defects research. 114 (20), pp. 1440-1448. [Online].